A carregar...
CRMP2 phosphorylation drives glioblastoma cell proliferation
Glioblastoma (GBM) is an aggressive primary brain tumor. The rapid growth and the privileged provenance of the tumor within the brain contribute to its aggressivity and poor therapeutic targeting. A poor prognostic factor in glioblastoma is the deletion or mutation of the Nf1 gene. This gene codes f...
Na minha lista:
| Publicado no: | Mol Neurobiol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5745298/ https://ncbi.nlm.nih.gov/pubmed/28660485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12035-017-0653-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|